| News

ATAMYO THERAPEUTICS: THE NEW WEBSITE IS NOW ONLINE

The Atamyo Therapeutics website is now accessible! Atamyo's mission is to provide a new generation of quality gene therapies for patients with neuromuscular diseases.

 
Currently, the pipeline focuses on 5 subtypes of LGMD:
- LGMD-R9 / LGMD2I
- LGMD-R5 / LGMD2C
- LGMD-R1 / LGMD2A
- LGMD-R2 / LGMD2B
- LGMD-R3 / LGMD2D
 

©2020 GFBONLUS.IT - GRUPPO FAMILIARI BETA-SARCOGLICANOPATIE
+39 328 0075986 This email address is being protected from spambots. You need JavaScript enabled to view it.

Via Civasca 112 23018 Talamona - SO  Italia

Made by Betsoft